Literature DB >> 7973484

Carpal tunnel syndrome: a major complication in hemodialysis patients.

A Sivri1, R Celiker, C Sungur, Y G Kutsal.   

Abstract

In order to assess the prevalence of the carpal tunnel syndrome (CTS) suggestive of beta 2 microglobulin amyloid deposit in patients undergoing hemodialysis with cuprophan and acetate membrane, we studied 30 patients who had been receiving hemodialysis for varying lengths of time. Besides a standard physical and rheumatological examination, nerve conduction velocity studies were done in median and ulnar motorsensory nerves. 12 patients had normal findings, 12 had CTS (9 pure CTS, 3 with neuropathy), and 9 had peripheral neuropathy. Nerve dysfunction was independent of the disease underlying renal failure, the side of the dialysis access shunt and factors such as age and sex. We suggest that hemodialysis patients need frequent EMG analysis to identify CTS early and to avoid irreversible nerve damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7973484     DOI: 10.3109/03009749409103731

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  Sonographic findings in haemodialysis-related chronic arthropathy.

Authors:  G Coari; A Iagnocco; S Maggi; M Bracci; A De Cata; M Mastantuono; M Larciprete; S Persichetti
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  A neurophysiological study of large- and small-diameter nerve fibers in the hands of hemodialysis patients.

Authors:  Miro Denislic; Merita Tiric-Campara; Halima Resić; Jasem Y Al-Hashel; Rok Zorec; Refet Gojak; Jan Ravnik
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

3.  Does carpal tunnel release provide long-term relief in patients with hemodialysis-associated carpal tunnel syndrome?

Authors:  Ho Jung Kang; Il Hyun Koh; Won Yong Lee; Yun Rak Choi; Soo Bong Hahn
Journal:  Clin Orthop Relat Res       Date:  2012-03-08       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.